phenylalanine has been researched along with B16 Melanoma in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (11.43) | 18.7374 |
| 1990's | 24 (68.57) | 18.2507 |
| 2000's | 6 (17.14) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimoto, T; Fukumori, Y; Ichikawa, H; Taniguchi, E | 1 |
| Akisue, T; Andoh, T; Epstein, AL; Fujimoto, T; Fujita, I; Fukumori, Y; Ichikawa, H; Imabori, M; Kirihata, M; Kurosaka, M; Moritake, H; Sakuma, Y; Sonobe, H; Sudo, T; Sugimoto, T; Takeuchi, T | 1 |
| LUCK, JM | 2 |
| Libert, C; López-Otin, C; Shapiro, S; Van Laere, I; Van Lint, P; Van Roy, M; Wielockx, B; Wilson, C | 1 |
| Aslakson, CJ; Elstad, CA; Meadows, GG; Starkey, JR | 1 |
| Brown, PD | 1 |
| Carlsson, J; Larsson, BS; Lindström, P; Olsson, P; Pettersson, OA; Sjöberg, S | 1 |
| Bawden, LJ; Brown, PD; Chirivi, RG; Crimmin, MJ; Garofalo, A; Giavazzi, R; Stoppacciaro, A | 1 |
| Ido, T; Ishiwata, K; Kubota, K; Kubota, R; Tada, M; Yamada, S | 1 |
| Huijzer, JC; McFarland, M; Meadows, GG; Niles, RM | 1 |
| Cardeiro, DJ; Elstad, CA; Huijzer, JC; Meadows, GG; Uhlenkott, CE | 1 |
| Brown, PD; Giavazzi, R | 1 |
| Elstad, CA; Meadows, GG; Raha, G; Thrall, BD | 1 |
| Comolli, R; La Porta, CA | 1 |
| Ferrans, VJ; Fu, YM; Meadows, GG; Yu, ZX | 1 |
| Ferrans, VJ; Fu, YM; Meadows, GG; Pelayo, BA; Yu, ZX | 1 |
| Chambers, AF; Groom, AC; MacDonald, IC; Morris, VL; Schmidt, EE; Varghese, HJ; Wylie, S | 1 |
| Hiratsuka, J; Imajo, Y; Kondoh, H; Mishima, Y; Yoshino, K | 1 |
| Hiratsuka, J; Imajo, Y; Kondoh, H; Mishima, Y; Tsuboi, T; Yoshino, K | 1 |
| Fernandez, N; Kazanietz, MG; Rotenberg, SA; Sanz-Navares, E | 1 |
| Ehara, K; Hiratsuka, J; Iwakura, M; Kondoh, H; Mishima, Y; Tamaki, N | 1 |
| Hori, Y; Ichihashi, M; Komura, A; Mishima, Y; Shiono, M; Yamamura, K; Yoshino, K | 1 |
| Mishima, Y | 1 |
| Hatazawa, J; Honda, C; Ichihashi, M; Ido, T; Ishiwata, K; Kubota, K; Mishima, Y; Shiono, M; Yoshino, K | 1 |
| Allen, BJ; Corderoy-Buck, S; Crotty, K; Mallesch, JL; Moore, DE | 1 |
| Honda, C; Ichihashi, M; Ido, T; Ishiwata, K; Kawamura, M; Mishima, Y | 1 |
| Hatanaka, H; Komada, F; Mishima, Y; Okumura, K; Shiono, M | 1 |
| Coderre, J; Fairchild, R; Hansrote, J; Packer, S; Perry, H; Saraf, S | 1 |
| Ciallella, JR; Coderre, JA; Micca, PL; Slatkin, DN | 1 |
| Jara, JR; Martinez-Liarte, JH; Peñafiel, R; Solano, F | 1 |
| Coderre, JA; Glass, JD; Greenberg, D; Micca, P; Packer, S | 1 |
| Coderre, JA; Fairchild, RG; Glass, JD; Micca, P | 1 |
| Hiratsuka, J; Kono, M; Mishima, Y | 1 |
2 review(s) available for phenylalanine and B16 Melanoma
| Article | Year |
|---|---|
Matrix metalloproteinase inhibition: a review of anti-tumour activity.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Humans; Melanoma, Experimental; Metalloendopeptidases; Neovascularization, Pathologic; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
A post melanosomal era: control of melanogenesis and melanoma growth.
Topics: Adolescent; Animals; Boron; Boron Compounds; Cricetinae; Fatty Acids, Unsaturated; Gene Expression Regulation, Neoplastic; Hair Color; Humans; Infant, Newborn; Isotopes; Male; Melanins; Melanocytes; Melanoma; Melanoma, Experimental; Models, Biological; Monophenol Monooxygenase; Neoplasm Proteins; Neutrons; Phenylalanine; Pigmentation Disorders; Protein Processing, Post-Translational; Pyrones; Radiation-Sensitizing Agents; Skin Pigmentation; Subcellular Fractions; Swine | 1992 |
33 other study(ies) available for phenylalanine and B16 Melanoma
| Article | Year |
|---|---|
Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
Topics: Animals; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Female; Isotopes; Melanoma, Experimental; Mesocricetus; Phenylalanine; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution | 2009 |
Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Humans; In Vitro Techniques; Melanoma, Experimental; Microscopy, Electron; Phenylalanine; Sarcoma, Clear Cell | 2011 |
Action of p-[di(2-chloroethyl)]-amino-l-phenylalanine on Harding-Passey mouse melanoma.
Topics: Animals; Melanoma, Experimental; Mice; Neoplasms, Experimental; Phenylalanine | 1956 |
Further observations on the efficacy of phenylalanine mustards against mouse melanoma.
Topics: Animals; Mechlorethamine; Melanoma, Experimental; Melphalan; Mice; Nitrogen Mustard Compounds; Phenylalanine | 1961 |
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Interferon-gamma; Matrix Metalloproteinase 12; Matrix Metalloproteinase 7; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenylalanine; Reverse Transcriptase Polymerase Chain Reaction; Thiophenes; Tissue Inhibitor of Metalloproteinases; Tumor Necrosis Factor-alpha | 2007 |
Evidence for nutrient modulation of tumor phenotype: impact of tyrosine and phenylalanine restriction.
Topics: Animal Nutritional Physiological Phenomena; Animals; Diet; Female; Killer Cells, Natural; Lung; Mast Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Phenylalanine; Tumor Cells, Cultured; Tyrosine | 1994 |
Matrix metalloproteinase inhibitors: a novel class of anticancer agents.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Female; Humans; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Phenylalanine; Protease Inhibitors; Thiophenes | 1995 |
Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Survival; Glioma; Humans; Melanins; Melanoma; Melanoma, Experimental; Phenylalanine; Protein Binding; Tumor Cells, Cultured | 1994 |
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
Topics: Animals; Cell Division; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Melanoma, Experimental; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Phenylalanine; Thiophenes; Tissue Distribution | 1994 |
Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Cell Division; Disease Models, Animal; DNA, Neoplasm; Fluorine Radioisotopes; Male; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Transplantation; Phenylalanine; Pigmentation; Radionuclide Imaging | 1993 |
Phorbol 12-myristate 13-acetate enhances nm23 gene expression in murine melanocytes but not in syngeneic B16-BL6 melanoma variants.
Topics: Animals; Cell Division; Cell Membrane; Cytosol; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Melanocytes; Melanoma, Experimental; Mice; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Phenylalanine; Protein Kinase C; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Transcription Factors; Tumor Cells, Cultured; Tyrosine | 1996 |
Attachment, invasion, chemotaxis, and proteinase expression of B16-BL6 melanoma cells exhibiting a low metastatic phenotype after exposure to dietary restriction of tyrosine and phenylalanine.
Topics: Animals; Cell Adhesion; Chemotaxis; Diet; Melanoma, Experimental; Metalloendopeptidases; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Phenylalanine; Plasminogen Activators; Receptors, Fibronectin; Tyrosine | 1996 |
Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Doxorubicin; Drug Resistance, Neoplasm; Leukemia P388; Melanoma, Experimental; Mice; Phenylalanine; Tumor Cells, Cultured; Tyrosine; Verapamil | 1996 |
Activation of protein kinase C-alpha isoform in murine melanoma cells with high metastatic potential.
Topics: Animals; Cathepsin B; Cell Culture Techniques; DNA, Neoplasm; Enzyme Activation; Isoenzymes; Melanoma, Experimental; Mice; Neoplasm Metastasis; Phenylalanine; Protein Kinase C; Tumor Cells, Cultured; Tyrosine | 1997 |
Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Cell Cycle; Culture Media; Cyclins; Diet; Female; Flow Cytometry; Immune Sera; Melanoma, Experimental; Methionine; Mice; Phenylalanine; Proliferating Cell Nuclear Antigen; Rabbits; Rats; Specific Pathogen-Free Organisms; Time Factors; Tumor Cells, Cultured; Tyrosine | 1997 |
Focal adhesion kinase-dependent apoptosis of melanoma induced by tyrosine and phenylalanine deficiency.
Topics: Animals; Apoptosis; Calcium; Cell Adhesion Molecules; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Humans; Intracellular Fluid; Melanoma; Melanoma, Experimental; Mice; Phenylalanine; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-myc; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tyrosine | 1999 |
The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
Topics: Animals; Cell Movement; Cell Survival; Injections, Intraperitoneal; Injections, Intravenous; Liver Neoplasms; Melanoma, Experimental; Mesenteric Veins; Mice; Microscopy, Video; Neovascularization, Pathologic; Phenylalanine; Thiophenes; Tumor Cells, Cultured | 1999 |
Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Male; Melanins; Melanoma, Experimental; Mesocricetus; Mice; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution | 2000 |
Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
Topics: Animals; Boron Compounds; Gene Expression; Humans; Melanins; Melanoma, Amelanotic; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Phenylalanine; Radiation-Sensitizing Agents; Transfection; Tumor Cells, Cultured | 2000 |
Atypical protein kinase Czeta suppresses migration of mouse melanoma cells.
Topics: Animals; Apoptosis Regulatory Proteins; Blotting, Western; Carrier Proteins; Cell Adhesion; Cell Line; Cell Movement; Cell Separation; Cells, Cultured; DNA, Complementary; Down-Regulation; Intracellular Signaling Peptides and Proteins; Melanins; Melanoma, Experimental; Mice; Mutagenesis, Site-Directed; Neoplasm Metastasis; Phenylalanine; Precipitin Tests; Protein Kinase C; Structure-Activity Relationship; Transfection; Tumor Cells, Cultured; Tyrosine | 2001 |
Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain.
Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Isotopes; Melanins; Melanoma, Amelanotic; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Phenylalanine; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2002 |
In vitro radiobiological analysis of 10B-L-BPA for BNCT of malignant melanoma: correlation of determined 10B-content and cell killing effect.
Topics: Animals; Boron; Boron Compounds; Dose-Response Relationship, Radiation; Fibroblasts; Humans; Isotopes; Mass Spectrometry; Melanoma, Experimental; Mice; Neutrons; Phenylalanine; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1992 |
A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
Topics: Animals; Boron Compounds; Cricetinae; Fluorine Radioisotopes; Melanoma, Experimental; Mesocricetus; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neutron Capture Therapy; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed | 1992 |
Local control of subcutaneous murine melanoma xenografts in nude mice by neutron capture therapy.
Topics: Animals; Boron Compounds; Cell Division; Cell Line; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Neutron Capture Therapy; Phenylalanine; Radiation-Sensitizing Agents; Skin; Skin Neoplasms | 1992 |
4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.
Topics: Animals; Autoradiography; Boron Compounds; Carbon Radioisotopes; Cricetinae; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Melanoma, Experimental; Mesocricetus; Mice; Neoplasm Transplantation; Phenylalanine; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Whole-Body Counting | 1992 |
Tissue distribution of para-boronophenylalanine administered orally as a cyclodextrin inclusion complex to melanoma-bearing hamsters.
Topics: Administration, Oral; Animals; Boron Compounds; Cricetinae; Cyclodextrins; Male; Melanoma, Experimental; Mesocricetus; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Inbred Strains; Skin Neoplasms; Tissue Distribution | 1992 |
Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Topics: Administration, Oral; Animals; Anterior Chamber; Autoradiography; Boron; Boron Compounds; Disease Models, Animal; Eye Neoplasms; Isotopes; Melanoma, Experimental; Neutrons; Phenylalanine; Rabbits; Radiation-Sensitizing Agents | 1992 |
Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index.
Topics: Animals; Boron Compounds; Dose-Response Relationship, Radiation; Melanoma, Experimental; Mice; Neutrons; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; X-Ray Therapy | 1991 |
Transport of L-tyrosine by B16/F10 melanoma cells: the effect of the intracellular content of other amino acids.
Topics: Amino Acids; Animals; Biological Transport; Melanoma, Experimental; Phenylalanine; Tumor Cells, Cultured; Tyrosine | 1990 |
Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
Topics: Animals; Boron; Boron Compounds; Eye Neoplasms; Isotopes; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neutrons; Phenylalanine; Rabbits; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1990 |
Eliminating phenylalanine and tyrosine from diet slows cancer spread.
Topics: Animals; Melanoma, Experimental; Mice; Phenylalanine; Tyrosine | 1990 |
Neutron capture therapy for melanoma.
Topics: Animals; Fast Neutrons; Female; Gamma Rays; Isotopes; Melanins; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neutrons; Phenylalanine; Radiotherapy; Radiotherapy Dosage; Thymidine; Tritium | 1989 |
[RBEs of thermal neutron capture therapy and 10B(n, alpha)7Li reaction on melanoma bearing hamster].
Topics: Animals; Boron Compounds; Cricetinae; Isotopes; Lithium; Melanoma, Experimental; Mesocricetus; Neutrons; Phenylalanine; Relative Biological Effectiveness | 1988 |